바이오인

Limiting the growth of health care costs and improving population health are among the most important and diicult challenges facing U.S. policymakers. he role of innovation in advanc-ing these social goals is controversial, with many seeing innovation as a major source of cost growth and many others viewing innovation as necessary for improving the quality of care and health outcomes. We argue that mitigating the tension between promoting health and controlling costs requires more-nuanced perspectives on innovation and its role in the health care system. We focus on innovation that increases U.S. capabilities or know-how related to diagnosing and treating medical conditions—that is, “medical technology” broadly deined to include drugs, devices, and methods of delivering health care—and we consider innova-tion in health care inancing only to the extent that it may afect invention and use of medical technologies.